LOGIN
Triamcinolone hexacetonide favoured to botulinum toxin and saline injection for treatment of knee OA
July 2019
Triamcinolone hexacetonide favoured to botulinum toxin and saline injection for treatment of knee OA
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A
Comparison between intra-articular Botulinum toxin type A, corticosteroid, and saline in knee osteoarthritis: a randomized controlled trial
Clin Rehabil. 2019 Jun;33(6):1015-1026.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
105 patients diagnosed with mild-to-moderate knee osteoarthritis were randomized to receive an intra-articular injection of botulinum toxin type A (BTA), triamcinolone hexacetonide (TH) or 0.9% saline. The primary outcome of interest was pain during movement, measured on a Visual Analog Scale (VAS). Secondary outcomes of interest included VAS pain at rest, the Western Ontario and McMaster Universi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.